Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Institute of Health Research, College of Medicine and Health, University of Exeter, Exeter, United Kingdom.
JAMA Psychiatry. 2021 Aug 1;78(8):868-875. doi: 10.1001/jamapsychiatry.2021.0823.
Depression frequently recurs. To prevent relapse, antidepressant medication is often taken in the long term. Sequentially delivering a psychological intervention while undergoing tapering of antidepressant medication might be an alternative to long-term antidepressant use. However, evidence is lacking on which patients may benefit from tapering antidepressant medication while receiving a psychological intervention and which should continue the antidepressant therapy. A meta-analysis of individual patient data with more power and precision than individual randomized clinical trials or a standard meta-analysis is warranted.
To compare the associations between use of a psychological intervention during and/or after antidepressant tapering vs antidepressant use alone on the risk of relapse of depression and estimate associations of individual clinical factors with relapse.
PubMed, the Cochrane Library, Embase, and PsycInfo were last searched on January 23, 2021. Requests for individual participant data from included randomized clinical trials (RCTs) were sent.
Randomized clinical trials that compared use of a psychological intervention while tapering antidepressant medication with antidepressant monotherapy were included. Patients had to be in full or partial remission from depression. Two independent assessors conducted screening and study selection.
Of 15 792 screened studies, 236 full-text articles were retrieved, and 4 RCTs that provided individual participant data were included.
Time to relapse and relapse status over 15 months measured via a blinded assessor using a diagnostic clinical interview.
Individual data from 714 participants (mean [SD] age, 49.2 [11.5] years; 522 [73.1%] female) from 4 RCTs that compared preventive cognitive therapy or mindfulness-based cognitive therapy during and/or after antidepressant tapering vs antidepressant monotherapy were available. Two-stage random-effects meta-analysis found no significant difference in time to depressive relapse between use of a psychological intervention during tapering of antidepressant medication vs antidepressant therapy alone (hazard ratio [HR], 0.86; 95% CI, 0.60-1.23). Younger age at onset (HR, 0.98; 95% CI, 0.97-0.99), shorter duration of remission (HR, 0.99; 95% CI, 0.98-1.00), and higher levels of residual depressive symptoms at baseline (HR, 1.07; 95% CI, 1.04-1.10) were associated with a higher overall risk of relapse. None of the included moderators were associated with risk of relapse.
The findings of this individual participant data meta-analysis suggest that regardless of the clinical factors included in these studies, the sequential delivery of a psychological intervention during and/or after tapering may be an effective relapse prevention strategy instead of long-term use of antidepressants. These results could be used to inform shared decision-making in clinical practice.
抑郁症经常复发。为了防止复发,经常需要长期服用抗抑郁药物。在逐渐减少抗抑郁药物的同时提供心理干预可能是替代长期使用抗抑郁药物的一种方法。然而,缺乏证据表明,在哪些患者中,减少抗抑郁药物的使用同时接受心理干预可能会受益,哪些患者应该继续接受抗抑郁治疗。需要进行一项个体患者数据的荟萃分析,以比个体随机临床试验或标准荟萃分析更有力量和精度来证明这一点。
比较在减少抗抑郁药物期间和/或之后使用心理干预与单独使用抗抑郁药物治疗对抑郁症复发风险的影响,并估计个体临床因素与复发的关系。
PubMed、Cochrane 图书馆、Embase 和 PsycInfo 于 2021 年 1 月 23 日最后一次检索。向纳入的随机临床试验(RCT)发送了个人参与者数据的请求。
纳入了比较在减少抗抑郁药物期间同时使用心理干预与单独使用抗抑郁药物治疗的 RCT。患者必须从抑郁症中完全或部分缓解。两名独立评估者进行了筛选和研究选择。
在筛选出的 15792 项研究中,检索到 236 篇全文文章,其中 4 项 RCT 提供了个体参与者数据。
在 15 个月内通过盲法评估者使用诊断性临床访谈测量复发时间和复发状态。
来自 4 项 RCT 的 714 名参与者(平均[标准差]年龄为 49.2[11.5]岁;522[73.1%]为女性)的个体数据可用于比较在减少抗抑郁药物期间和/或之后使用预防性认知疗法或基于正念的认知疗法与单独使用抗抑郁药物治疗。两阶段随机效应荟萃分析发现,在减少抗抑郁药物期间使用心理干预与单独使用抗抑郁药物治疗相比,抑郁复发的时间无显著差异(危险比[HR],0.86;95%CI,0.60-1.23)。发病年龄较小(HR,0.98;95%CI,0.97-0.99)、缓解期较短(HR,0.99;95%CI,0.98-1.00)和基线时残留抑郁症状水平较高(HR,1.07;95%CI,1.04-1.10)与整体复发风险较高相关。纳入的调节因素均与复发风险无关。
这项个体参与者数据荟萃分析的结果表明,无论这些研究中包括哪些临床因素,在减少和/或之后同时提供心理干预可能是一种有效的预防复发策略,而不是长期使用抗抑郁药物。这些结果可以用于为临床实践中的共同决策提供信息。